[1]
C. C. Tussey, MD, M. D. Reyes, PharmD, R. B. Thomas, MEd LCAS, C. T. Boyd, MA, CHES, J. G. Spangler, MD, MPH, and J. K. Kirk, PharmD, CDE, BCPS, “Utility of the group medical visit model for medication-assisted therapy”, J of Opioid Management, vol. 18, no. 1, pp. 69–74, Jan. 2022.